The Expanding Prominence of Toxic Leukoencephalopathy
J Neuropsychiatry Clin Neurosci 29:308-318, Filley,C.M.,et al, 2017
The Many Faces of Posterior Reversible Encephalopathy Syndrome
Br J Radiol 85:1566-1575, Stevens, C.J. & Heran, M.K.S., 2012
Clinicopath Conf, Inflamatory Cerebral Amyloid Angiopathy,
NEJM 363:373-381, Case 22-2010, 2010
CNS Complications of Radiotherapy and Chemotherapy
Lancet 374:1639-1651, Soussain,C.,et al, 2009
Monoclonal Antibody Therapies and Neurologic Disorders
Arch Neurol 65:1162-1165, Novack,J.C.,et al., 2008
Sirolimus-Induced Posterior Reversible Encephalopathy
Neurol 68:2039-2040, Bodkin,C.L. &Eidelman,B.H., 2007
Reversible Posterior Leukoencephalopathy Syndrome and Bevacizumab
NEJM 354:980-982, Ozcan,C.,et al, 2006
Intravascular Lymphomatosis Presenting as Posterior Leukoencephalopathy
Arch Neurol 59:640-641, Moussouttas,M., 2002
Reversible Posterior Leukoencephalopathy During the Treatment of Acute Lymphoblastic Leukemia
Neurol 56:388-391, Shin,R.K.,et al, 2001
Cerebral Amyloid Angiopathy Presenting as Nonhemorrhagic Diffuse Encephalopathy: Neuropathologic and Neuroradiologic Manifestations in One Case
AJNR 22:1072-1076, Caulo,M.,et al, 2001
Gemcitabine-Associated Posterior Reversible Encephalopathy Syndrome: MR Imaging and MR Spectroscopy Findings
Magnetic Resonance Imaging 19:129-132, Russell,M.T,et al, 2001
Cisplatin Neurotoxicity Presenting as Reversible Posterior Leukoencephalopathy Syndrome
AJNR 19:415-417, 5911998., Ito,Y.,et al, 1998
Acute Leukoencephalopathies:Differential Diagnosis and Investigation
The Neurologist 4:148-166, Weinshenker,B.G.,et al, 1998
Erythropoietin-Associated Hypertensive Posterior Leukoencephalopathy
Neurol 49:686-689, Delanty,N.,et al, 1997
A Reversible Posterior Leukoencephalopathy Syndrome
NEJM 334:494-500, Hinchey,J.,et al, 1996
Leukoencephalopathy Associated with Cobalamin Deficiency
Neurol 46:832-834, Chatterjee,A.,et al, 1996
Leukoencephalopathy in Cerebral Amyloid Angiography: MR Imaging in Four Cases
AJNR 11:485-488, Loes,D.J.,et al, 1990